These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 14656255)
1. New and emerging drug therapies for the management of acute heart failure. Krum H; Liew D Intern Med J; 2003 Nov; 33(11):515-20. PubMed ID: 14656255 [TBL] [Abstract][Full Text] [Related]
2. Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure. Teerlink JR Am Heart J; 2003 Feb; 145(2 Suppl):S26-33. PubMed ID: 12594449 [No Abstract] [Full Text] [Related]
3. Pharmacological therapy of acute cardiogenic pulmonary oedema in the emergency department. Graham CA Emerg Med Australas; 2004 Feb; 16(1):47-54. PubMed ID: 15239755 [TBL] [Abstract][Full Text] [Related]
4. The development of new medical treatments for acute decompensated heart failure. Teerlink JR Heart Fail Monit; 2002; 2(4):129-37. PubMed ID: 12634887 [TBL] [Abstract][Full Text] [Related]
6. Optimizing outcomes in the patient with acute decompensated heart failure. Mehra MR Am Heart J; 2006 Mar; 151(3):571-9. PubMed ID: 16504617 [TBL] [Abstract][Full Text] [Related]
7. New therapeutic choices in the management of acute congestive heart failure. Young JB Rev Cardiovasc Med; 2001; 2 Suppl 2():S19-24. PubMed ID: 12439358 [TBL] [Abstract][Full Text] [Related]
8. New therapies for heart failure. Riggs JM RN; 2004 Mar; 67(3):28-32; quiz 33. PubMed ID: 15065491 [No Abstract] [Full Text] [Related]
9. Overview of emerging pharmacologic agents for acute heart failure syndromes. De Luca L; Mebazaa A; Filippatos G; Parissis JT; Böhm M; Voors AA; Nieminen M; Zannad F; Rhodes A; El-Banayosy A; Dickstein K; Gheorghiade M Eur J Heart Fail; 2008 Feb; 10(2):201-13. PubMed ID: 18279775 [TBL] [Abstract][Full Text] [Related]
10. Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization. Jain P; Massie BM; Gattis WA; Klein L; Gheorghiade M Am Heart J; 2003 Feb; 145(2 Suppl):S3-17. PubMed ID: 12594447 [No Abstract] [Full Text] [Related]
11. The disconnect between phase II and phase III trials of drugs for heart failure. Vaduganathan M; Greene SJ; Ambrosy AP; Gheorghiade M; Butler J Nat Rev Cardiol; 2013 Feb; 10(2):85-97. PubMed ID: 23296069 [TBL] [Abstract][Full Text] [Related]
12. Levosimendan use in several scenarios of acute heart failure. Tavares M; Andrade AC; Mebazaa A Arq Bras Cardiol; 2008 Mar; 90(3):211-5. PubMed ID: 18392402 [TBL] [Abstract][Full Text] [Related]
13. Current and novel pharmacological approaches to renal insufficiency in heart failure. Hindnavis V; Tang WH Minerva Cardioangiol; 2006 Dec; 54(6):753-62. PubMed ID: 17167387 [TBL] [Abstract][Full Text] [Related]
14. The role of intravenous vasodilators in acute heart failure management. Piper S; McDonagh T Eur J Heart Fail; 2014 Aug; 16(8):827-34. PubMed ID: 25100108 [TBL] [Abstract][Full Text] [Related]
15. Newer approaches to the pharmacological management of heart failure. Rauch H; Motsch J; Böttiger BW Curr Opin Anaesthesiol; 2006 Feb; 19(1):75-81. PubMed ID: 16547437 [TBL] [Abstract][Full Text] [Related]
16. Management of heart failure: a brief review and selected update. Unzek S; Francis GS Cardiol Clin; 2008 Nov; 26(4):561-71. PubMed ID: 18929231 [TBL] [Abstract][Full Text] [Related]
18. Levosimendan: A promising agent for the treatment of hospitalized patients with decompensated heart failure. Lehtonen L Curr Cardiol Rep; 2000 May; 2(3):233-43. PubMed ID: 10980898 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of nesiritide in patients with acute decompensated heart failure. DeWald TA; Hernandez AF Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):159-69. PubMed ID: 20136602 [TBL] [Abstract][Full Text] [Related]